Ingrid Øra
31 – 40 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
A Phase I study of inotuzumab ozogamicin in pediatric relapsed/refractory acute lymphoblastic leukemia (ITCC-059 study)
(2020) In Blood
- Contribution to journal › Article
-
Mark
Cognitive fatigue in relation to depressive symptoms after treatment for childhood cancer
- Contribution to journal › Article
-
Mark
Low bone mineral density is associated with hypogonadism and cranial irradiation in male childhood cancer survivors
- Contribution to journal › Article
-
Mark
Increased cancer risk in families with pediatric cancer is associated with gender, age, diagnosis, and degree of relation to the child
(2020) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29(11). p.2171-2179
- Contribution to journal › Article
-
Mark
Neurologic disorders in long-term survivors of neuroblastoma–a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia (ALiCCS) research program
- Contribution to journal › Article
- 2019
-
Mark
Anti-müllerian hormone compared with other ovarian markers after childhood cancer treatment
- Contribution to journal › Article
- 2018
-
Mark
Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer
- Contribution to journal › Article
-
Mark
Somatic late effects in 5-year survivors of neuroblastoma : a population-based cohort study within the Adult Life after Childhood Cancer in Scandinavia study
- Contribution to journal › Article
-
Mark
Neuroblastoma with flat genomic profile : A question of representativity?
- Contribution to journal › Article
-
Mark
Patient-derived xenograft models reveal intratumor heterogeneity and temporal stability in neuroblastoma
- Contribution to journal › Article
